You are viewing an incomplete version of our website. Please click to reload the website as full version.

anti-Human TNFRSF10C antibody for Flow Cytometry

Recommended TNFRSF10C Antibody (supplied by: Log in to see )

Antigen
Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) Antibodies
  • CD263
  • DCR1
  • DCR1-TNFR
  • LIT
  • TRAIL-R3
  • TRAILR3
  • TRID
  • TNFRSF10C
  • tumor necrosis factor receptor superfamily, member 10c, decoy without an intracellular domain
  • TNFRSF10C
Epitope
AA 1-221
31
15
9
7
7
4
2
1
1
1
1
1
1
1
1
1
Reactivity
Human
137
17
14
7
Host
Mouse
93
47
4
3
Clonality
Monoclonal
Conjugate
This TNFRSF10C antibody is un-conjugated
20
15
3
3
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Application
Flow Cytometry (FACS)
89
64
22
17
11
8
6
3
2
2
2
1
1
1
Supplier
Log in to see
Supplier Product No.
Log in to see
Request

Get this product for free

It's quick and easy to submit your validation proposal. I want to validate this product

Learn more

Available images

Catalog No. ABIN4899000
Contact our Customer Service for availability and price in your country.
Relevance Score ABIN Application Conjugate Host Isotype Epitope Supplier Clonality References Details
13.411841 ABIN4895308 FACS PE Mouse IgG1 AA 1-221 Log in to see 90906 7
13.411841 ABIN2663243 FACS PE Mouse IgG1 kappa Log in to see DJR3 3
13.411841 ABIN2497095 FACS PE Mouse IgG1 Log in to see
13.411841 ABIN4895307 FACS Allophycocyanin Mouse IgG1 AA 1-221 Log in to see 90906
13.411841 ABIN2497094 FACS FITC Mouse IgG1 Log in to see
13.411841 ABIN2497093 FACS FITC Mouse IgG1 Log in to see
13.411841 ABIN2497098 FACS IP Mouse IgG1 Log in to see
13.411841 ABIN2497097 FACS IP Mouse IgG1 Log in to see
13.411841 ABIN187537 FACS IF Mouse IgG1 Log in to see HS301
13.411841 ABIN2479552 FACS IP Mouse IgG1 Log in to see 2B8
1 ABIN487315 FACS PE Mouse IgG1 AA 1-280, N-Term Log in to see TRAIL-R3-02 5
1 ABIN1106171 FACS PE Mouse IgG1 Log in to see B-D44 2
1 ABIN487314 FACS FITC Mouse IgG1 AA 1-280, N-Term Log in to see TRAIL-R3-02 5
1 ABIN1106170 FACS Mouse IgG1 Log in to see B-D44 1
1 ABIN238512 FACS Mouse IgG1 AA 1-280, N-Term Log in to see TRAIL-R3-02 5
1 ABIN1169230 ICC FACS Mouse IgG1 Log in to see HS301 4
1 ABIN187538 FACS WB Mouse IgG2a Log in to see LEIA
1 ABIN301991 FACS Mouse IgG1 AA 1-280 Log in to see TRAIL-R3-02 4
1 ABIN474545 FACS PE Mouse IgG1, kappa Log in to see DJR3
1 ABIN1169229 FACS IHC WB Mouse IgG1 Log in to see TR3-06

Top referenced anti-TNFRSF10C antibody for Flow Cytometry

  • Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN4899000 (11 Publications): Barbarotto, Corallini, Rimondi, Fadda, Mischiati, Grill, Vaccarezza, Celeghini: Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells. in Journal of cellular biochemistry 2008 (PubMed)

  • Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN4895308 (7 Publications): Gojo, Tan, Fang, Sadowska, Lapidus, Baer, Carrier, Beumer, Anyang, Srivastava, Espinoza-Delgado, Ross: Translational phase I trial of vorinostat (suberoylanilide hydroxamic acid) combined with cytarabine and etoposide in patients with relapsed, refractory, or high-risk acute myeloid leukemia. in Clinical cancer research : an official journal of the American Association for Cancer Research 2013 (PubMed)

  • Human Monoclonal TNFRSF10C Primary Antibody for ICC, FACS - ABIN1169230 (4 Publications): Wachter, Sprick, Hausmann, Kerstan, McPherson, Stassi, Bröcker, Walczak, Leverkus: cFLIPL inhibits tumor necrosis factor-related apoptosis-inducing ligand-mediated NF-kappaB activation at the death-inducing signaling complex in human keratinocytes. in The Journal of biological chemistry 2004 (PubMed)

  • Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN1383917 (2 Publications): Baritaki, Katsman, Chatterjee, Yeung, Spandidos, Bonavida: Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation. in Journal of immunology (Baltimore, Md. : 1950) 2007 (PubMed)

  • Human Monoclonal TNFRSF10C Primary Antibody for FACS - ABIN1383918 (1 Publications): Mérino, Lalaoui, Morizot, Schneider, Solary, Micheau: Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2. in Molecular and cellular biology 2006 (PubMed)

Similar anti-TNFRSF10C Antibodies

Application / Reactivity Human
Cytometry by Time of Flight (CyTOF) 1 Antibodies
ELISA 14 Antibodies
Enzyme Immunoassay (EIA) 1 Antibodies
Flow Cytometry (FACS) 90 Antibodies
Functional Studies (Func) 2 Antibodies
Immunochromatography (IC) 2 Antibodies
Immunocytochemistry (ICC) 11 Antibodies
Immunofluorescence (IF) 6 Antibodies
Immunofluorescence (fixed cells) (IF/ICC) 1 Antibodies
Immunohistochemistry (IHC) 17 Antibodies
Immunohistochemistry (Frozen Sections) (IHC (fro)) 1 Antibodies
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) 3 Antibodies
Immunoprecipitation (IP) 8 Antibodies
Western Blotting (WB) 53 Antibodies

General

Antigen Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain (TNFRSF10C) Antibodies
Epitope AA 1-221
(31), (15), (9), (7), (7), (4), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Reactivity Human
(137), (17), (14), (7)
Host Mouse
(93), (47), (4), (3)
Clonality (Clone)
Monoclonal   ( )
Conjugate This TNFRSF10C antibody is un-conjugated
(20), (15), (3), (3), (2), (2), (2), (2), (2), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1), (1)
Application Flow Cytometry (FACS)
(89), (64), (22), (17), (11), (8), (6), (3), (2), (2), (2), (1), (1), (1)
Pubmed 11 references available
Supplier Log in to see

Product Details anti-TNFRSF10C Antibody

Target Details TNFRSF10C Application Details Handling References for anti-TNFRSF10C Antibody (ABIN4899000) Images
Specificity Detects human TRAIL R3/TNFRSF10C in direct ELISAs and Western blots. In direct ELISAs and Western blots, no cross-reactivity with recombinant human (rh) TRAIL R2, rhTRAIL R1, or rhTRAIL R4 is observed.
Purification Protein A or G purified from hybridoma culture supernatant
Sterility 0.2 μm filtered
Endotoxin Level <0.10 EU per 1 μg of the antibody by the LAL method.
Immunogen Mouse myeloma cell line NS0-derived recombinant human TRAIL R3/TNFRSF10C, Met1-Ala221, Accession # O14798
Clone 90906
Isotype IgG1

Target Details TNFRSF10C

Product Details anti-TNFRSF10C Antibody Application Details Handling References for anti-TNFRSF10C Antibody (ABIN4899000) Images back to top
Antigen
Alternative Name TRAIL R3/TNFRSF10C (TNFRSF10C Antibody Abstract)
Gene ID 8794
UniProt O14798
Pathways Apoptosis

Application Details

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Handling References for anti-TNFRSF10C Antibody (ABIN4899000) Images back to top
Application Notes Flow Cytometry 0.25 μg/10^6 cells, CyTOF-ready
Restrictions For Research Use only

Handling

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Application Details References for anti-TNFRSF10C Antibody (ABIN4899000) Images back to top
Reconstitution Reconstitute at 0.5 mg/mL in sterile PBS.
Buffer 0.2 μm filtered solution in PBS with Trehalose.
Preservative Without preservative
Storage 4 °C/-20 °C/-80 °C
Storage Comment Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Expiry Date 12 months

References for anti-TNFRSF10C Antibody (ABIN4899000)

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Application Details Handling Images back to top
Product cited in:

Neumann, Hasenauer, Pollak, Scheurich: "Dominant negative effects of tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) receptor 4 on TRAIL receptor 1 signaling by formation of heteromeric complexes." in: The Journal of biological chemistry, Vol. 289, Issue 23, pp. 16576-87, 2014

Moniri, Sun, Rayat, Dai, Ao, He, Verchere, Dai, Warnock: "TRAIL-engineered pancreas-derived mesenchymal stem cells: characterization and cytotoxic effects on pancreatic cancer cells." in: Cancer gene therapy, Vol. 19, Issue 9, pp. 652-8, 2012 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Zauli, Rimondi, Celeghini, Milani, Secchiero: "Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL)." in: Journal of cellular physiology, Vol. 222, Issue 2, pp. 357-64, 2009 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Stary, Klein, Kohlhofer, Koszik, Scherzer, Müllauer, Quendler, Kohrgruber, Stingl: "Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients." in: Blood, Vol. 114, Issue 18, pp. 3854-63, 2009 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Barbarotto, Corallini, Rimondi, Fadda, Mischiati, Grill, Vaccarezza, Celeghini: "Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells." in: Journal of cellular biochemistry, Vol. 104, Issue 2, pp. 595-605, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Toscano, Fajoui, Gay, Lalaoui, Parmentier, Chayvialle, Scoazec, Micheau, Abello, Saurin: "P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells." in: Oncogene, Vol. 27, Issue 30, pp. 4161-71, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Weinmann, Wischhusen, Demma, Naumann, Roth, Dasmahapatra, Weller: "A novel p53 rescue compound induces p53-dependent growth arrest and sensitises glioma cells to Apo2L/TRAIL-induced apoptosis." in: Cell death and differentiation, Vol. 15, Issue 4, pp. 718-29, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Shankar, Chen, Ganapathy, Singh, Srivastava: "Diallyl trisulfide increases the effectiveness of TRAIL and inhibits prostate cancer growth in an orthotopic model: molecular mechanisms." in: Molecular cancer therapeutics, Vol. 7, Issue 8, pp. 2328-38, 2008 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Braun, Fecker, Schwarz, Walden, Assaf, Dürkop, Sterry, Eberle: "Blockade of death receptor-mediated pathways early in the signaling cascade coincides with distinct apoptosis resistance in cutaneous T-cell lymphoma cells." in: The Journal of investigative dermatology, Vol. 127, Issue 10, pp. 2425-37, 2007 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Locklin, Federici, Espina, Hulley, Russell, Edwards: "Selective targeting of death receptor 5 circumvents resistance of MG-63 osteosarcoma cells to TRAIL-induced apoptosis." in: Molecular cancer therapeutics, Vol. 6, Issue 12 Pt 1, pp. 3219-28, 2007 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Singh, Shankar, Srivastava: "HDAC inhibitors enhance the apoptosis-inducing potential of TRAIL in breast carcinoma." in: Oncogene, Vol. 24, Issue 29, pp. 4609-23, 2005 Method employed by authors: Flow Cytometry (FACS) (Sample species: Human).

Images

Product Details anti-TNFRSF10C Antibody Target Details TNFRSF10C Application Details Handling References for anti-TNFRSF10C Antibody (ABIN4899000) back to top
Supplier Images
Flow Cytometry (FACS) image for anti-TNFRSF10C antibody (Tumor Necrosis Factor Receptor Superfamily, Member 10c, Decoy Without An Intracellular Domain) (AA 1-221) (ABIN4899000) Detection of TRAIL R3/TNFRSF10C in Human Blood Granulocytes by Flow Cytometry. Human ...